截至月份: 2025年7月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 綠景(中國)地產投資有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00095 | 說明 | 普通股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 30,000,000,000 | HKD | | 0.01 | HKD | | 300,000,000 ...

Group 1 - The core point of the news is that Hehua Co., Ltd. is planning a potential share transfer that may lead to a change in its controlling shareholder and actual controller, as notified by its major shareholder, Ningbo Yinyi Holdings Co., Ltd. [1] - The company has announced a temporary suspension of its stock trading starting from July 31, due to the uncertainty surrounding the share transfer, with an expected suspension period of no more than two trading days [3] - Hehua Co., Ltd. is also participating in the establishment of a venture capital fund with a total initial subscription of 11 million yuan, where the company will contribute 5 million yuan, accounting for 45.45% of the total [4] Group 2 - Hehua Co., Ltd. primarily engages in the research, production, and sales of pharmaceutical intermediates, as well as the commissioned processing and sales of urea [5] - On July 30, the company's stock price experienced a significant increase, reaching a closing price of 8.02 yuan per share, with a total market capitalization of 2.9 billion yuan [5][6]

Core Viewpoint - Hehua Co., Ltd. (河化股份) announced a suspension of its stock trading due to a planned change in control, with the suspension expected to last no more than two trading days [2][4]. Group 1: Company Background - Hehua Co., Ltd. primarily engages in the research, production, and sales of pharmaceutical intermediates, as well as the commissioned processing and sales of urea [5]. - The company’s subsidiary, Nansong Pharmaceutical, specializes in the development and production of pharmaceutical intermediates, with products sold domestically and internationally, including to countries like India and Finland [5]. - Hehua Co., Ltd. has undergone two changes in actual control since its establishment in 1993, with the current controlling shareholder being Ningbo Yinyi Holdings Co., Ltd. (银亿控股) since 2016 [5]. Group 2: Recent Developments - Ningbo Yinyi Holdings is currently planning a share transfer that may lead to a change in the controlling shareholder and actual controller of Hehua Co., Ltd. [4]. - The company reported a revenue of 40.83 million yuan in Q1, a year-on-year decrease of 34.05%, but achieved a net profit of 1.36 million yuan, marking a turnaround from losses [5]. - Hehua Co., Ltd. has faced operational challenges, including a significant decline in performance after the acquisition of Nansong Pharmaceutical, which was intended to pivot the business towards fine chemical production [8]. Group 3: Financial and Market Performance - Hehua Co., Ltd. has seen its stock price increase by over 40% this year, with a notable surge on July 30, when the stock hit the daily limit [9]. - The company is focusing on enhancing its core business and expanding market reach to identify new profit growth points [9].

Group 1 - The core point of the news is that Hehua Co., Ltd. (河化股份) is undergoing a potential change in its controlling shareholder and actual controller due to a planned equity transfer by its major shareholder, Ningbo Yinyi Holdings Co., Ltd. [1] - The company has announced a stock suspension starting from July 31, 2023, to ensure fair information disclosure and protect investor interests, with the suspension expected to last no more than two trading days [3] - Hehua Co., Ltd. has recently signed an agreement to invest 5 million yuan in a venture capital fund, aiming to optimize the efficiency of its capital usage and leverage professional resources to seize market opportunities [4] Group 2 - The total initial capital commitment for the venture capital fund is 11 million yuan, with Hehua Co., Ltd. contributing 5 million yuan, representing 45.45% of the total [4] - The fund will primarily invest in high-quality equity targets in the fields of raw material pharmaceutical enterprises and synthetic biomedicine, with an investment period of three years and an exit period of two years [4] - As of July 30, 2023, Hehua Co., Ltd.'s stock price experienced a significant increase, closing at 8.02 yuan per share, with a total market capitalization of 2.9 billion yuan [4]

【导读】控股股东筹划控制权变更，河化股份明日起停牌 7月30日晚间，河化股份发布公告称，公司收到控股股东宁波银亿控股有限公司的通知，其正在筹划股权转让相关事宜，该事项可能导致公司控股股东及 实际控制人发生变更。目前各方尚未签署正式交易协议，拟就相关事项进行进一步论证和磋商。 根据公告，该基金主要投资于原料药企业上下游、合成生物医药等行业领域优质股权标的企业，或全体合伙人认可的其他未上市企业股权。投资期为3 年，退出期为2年。 河化股份表示，此次投资旨在优化公司资金使用效率，借助专业机构资源把握市场机会，但对基金可能面临的政策、市场等风险需保持关注。本次投资资 金来源于公司自有资金，不会对财务状况和经营成果产生重大影响。 公开资料显示，河化股份主要从事医药中间体的研发、生产与销售业务以及尿素委托加工销售业务。 值得注意的是，7月30日，河化股份股价盘中异动拉升，快速涨停。截至收盘，河化股份股价报8.02元/股，总市值为29亿元。 （文章来源：中国基金报） 河化股份表示，鉴于该事项正在筹划中，具有较大不确定性。为保证公平信息披露，维护投资者利益，避免造成公司股价异常波动，公司股票自7月31日 上午开市起停牌，预计 ...

Core Viewpoint - The controlling shareholder of Hehua Co., Ltd. is planning a change in control, leading to a temporary suspension of the company's stock trading starting July 31 [1][3]. Group 1: Shareholder Control Change - Hehua Co., Ltd. announced that its controlling shareholder, Ningbo Yinyi Holdings Co., Ltd., is in the process of planning a share transfer, which may result in a change of the controlling shareholder and actual controller [1]. - No formal transaction agreements have been signed yet, and further discussions and evaluations are ongoing regarding this matter [1]. Group 2: Stock Suspension - Due to the ongoing planning of the shareholder control change, Hehua Co., Ltd. has decided to suspend its stock trading to ensure fair information disclosure and protect investor interests, with the suspension expected to last no more than two trading days [3]. Group 3: Investment Activities - Recently, Hehua Co., Ltd. has been active in investment, announcing on July 11 that it will invest 5 million yuan in establishing a venture capital fund in partnership with a professional investment institution and an individual [3]. - The total initial capital commitment for the fund is 11 million yuan, with Hehua Co., Ltd. holding a 45.45% stake [3]. - The fund will primarily invest in high-quality equity targets in the upstream and downstream of raw pharmaceutical enterprises and synthetic biological medicine, with an investment period of three years and an exit period of two years [3]. Group 4: Company Profile - Hehua Co., Ltd. is primarily engaged in the research, development, production, and sales of pharmaceutical intermediates, as well as the commissioned processing and sales of urea [4]. - On July 30, Hehua Co., Ltd. experienced a significant stock price increase, reaching a closing price of 8.02 yuan per share, with a total market capitalization of 2.9 billion yuan [4].

Group 1 - Binjiang Group successfully issued 600 million yuan of short-term financing bonds with an interest rate of 2.5%, reflecting a healthy financial status and improved financing environment for leading private real estate companies [1] - Sunac Real Estate's two office properties in Beijing are set to be auctioned due to a loan contract dispute, indicating ongoing financial pressure despite support for overseas debt restructuring [2] - Kaisa Group has completed 76% repayment of investment funds for its Jin Heng Wealth product, showcasing the company's commitment to resolving issues and restoring investor confidence [3] Group 2 - Greentown China Holdings' liquidation hearing has been postponed to August 4, 2025, allowing the company more time to address its financial crisis and seek effective solutions [4] - Xinyuan Real Estate has faced a significant lawsuit involving 350 million yuan, highlighting the worsening operational difficulties and the need for urgent resolution of legal disputes to improve financial conditions [5]

智通财经7月9日电，香港法院将绿景中国地产的清盘呈请聆讯推迟至8月4日。 ...

Important News - The US has adjusted tariffs on China as of May 14, 00:01 Eastern Time [1] - China Securities Depository and Clearing Corporation clarified that account verification is a routine operation, not a special arrangement for "off-market financing" [1] - The People's Bank of China reported that from January to April, the total social financing increased by 16.34 trillion yuan, with new loans amounting to 10.06 trillion yuan, and M2 growth year-on-year at 8% [1] Company News - Tencent (00700.HK) reported Q1 revenue of 180 billion yuan, a year-on-year increase of 13% [1] - China Petroleum & Chemical Corporation (00386.HK) received an increase of approximately 302 million H-shares from Sinopec Group [1] - Longfor Properties (06968.HK) reported contract sales of approximately 1.804 billion yuan in the first four months, a year-on-year decrease of 0.3% [1] - Oceanwide Holdings (03377.HK) reported cumulative contract sales of approximately 8.09 billion yuan in the first four months, a year-on-year increase of 13.62% [1] - New China Life Insurance (01336.HK) reported original insurance premium income of 85.3791 billion yuan in the first four months, a year-on-year increase of 27% [1] - China Pacific Insurance (02601.HK) reported original insurance premium income of 115.359 billion yuan from Pacific Life Insurance in the first four months, a year-on-year increase of 10.4% [1] - Heng Rui Medicine plans to issue 224.5 million shares in Hong Kong, with an issue price not exceeding 44.05 HKD [1] - Vanke Enterprises (02202.HK) announced that its largest shareholder, Shenzhen Metro Group, plans to provide a loan to the company not exceeding 1.552 billion yuan [1] - Greentown China Holdings (00095.HK) has postponed the hearing for its liquidation application to July 9 [1]

Group 1 - As of May 14, 78 stocks reached a 52-week high, with Chang'an Renheng (08139), Hengchang Group International (01421), and Lehua Entertainment (02306) leading the high rate at 65.38%, 42.59%, and 38.52% respectively [1] - The closing price of Chang'an Renheng was 1.370, with a peak price of 2.580, indicating a significant increase [1] - Hengchang Group International closed at 0.690, reaching a high of 0.770, reflecting a 42.59% increase [1] Group 2 - Lehua Entertainment's closing price was 1.510, with a maximum price of 1.690, showing a 38.52% rise [1] - XL Ernan CO (07711) and XL Ernan CO-U had increases of 27.75% and 26.89% respectively, with closing prices of 125.000 and 15.960 [1] - Other notable stocks include Madison Holdings (08057) with a 25.00% increase and Du Fu Wine Group (00986) with a 17.48% increase [1] Group 3 - The report also highlights stocks that reached 52-week lows, with XI Ernan CO (07311) dropping by 36.46% to a closing price of 26.500 [3] - XI Ernan CO-U saw a decrease of 35.53%, closing at 3.386 [3] - Other stocks with significant declines include Touyun Biotechnology (01332) at -22.46% and Aoweiholdings (01370) at -16.67% [3]